MondayJan 09, 2023 11:12 am

BMI Doesn’t Impact Intensity of Psychedelic Experiences

New research has found that the intensity of a psilocybin trip doesn’t depend on an individual’s body mass index (BMI). BMI is a measure of body fat based on height and weight that applies to adults. Psilocybin is the primary psychoactive compound found in hallucinogenic mushrooms. When ingested, this compound acts as a receptor agonist of 5-HT2A to activate serotonin receptors in the prefrontal cortex in the brain. This decreases the energy required by the brain to alternate between different activity states. A Center for Psychedelic Research research associate, Meg J. Spriggs, the author of the study, stated that the…

Continue Reading

FridayJan 06, 2023 11:44 am

Controlled Study Shows Single Modest Psilocybin Dose Cuts Depression Symptoms for a Fortnight

New research has found that one dose of psilocybin administered together with therapy significantly alleviates symptoms of depression. Psilocybin is the primary psychoactive compound found in magic mushrooms. This compound, which alters an individual’s state of consciousness when consumed, has been used for centuries in religious and spiritual rituals. In the last few years, numerous studies on psilocybin have been conducted to determine its potential therapeutic benefits. While promising results have been observed when the substance is used in managing anxiety and depression, more studies are required to fully understand the effectiveness of psilocybin therapy. The latest study, carried out…

Continue Reading

ThursdayJan 05, 2023 1:39 pm

New York Legislators File Measure to Legalize Psychedelics

Last week, legislators in New York filed a measure to legalize psychedelics such as ibogaine and psilocybin for the 2023 legislative session. The bill, which will be introduced formally this week, is being sponsored by assembly members Linda Rosenthal, Karines Reyes and Jo Anne Simon. The bill would make the use, possession, cultivation, creation, production, gifting, analysis, sharing or exchange of natural fungus or plant-based hallucinogens legal for individuals aged 21 and above. The psychedelics that will be legalized if the bill is approved include psilocybin, mescaline, psilocyn, ibogaine and DMT. The bill will also allow individuals to use the…

Continue Reading

WednesdayJan 04, 2023 11:50 am

Schools Step Up Training for Psychedelic Therapy Professionals

Psychedelic therapies are poised to revolutionize the psychiatric industry. With America’s mental health crisis getting worse by the year, researchers have been casting their attention on psychedelics for their potential mental-health benefits. Initial research into hallucinogenic drugs such as psilocybin and ketamine has revealed that they are capable of alleviating the symptoms of a variety of mental illnesses. As a result, pharmaceutical companies have been injecting millions of dollars into psychedelic research and the development of psychedelic-assisted therapies. Experts predict that the market for psychedelic drugs will grow explosively over the next decade, increasing from around $2 billion in 2020…

Continue Reading

TuesdayJan 03, 2023 3:44 pm

Three Trends That May Shape the Psychedelics Industry Next Year

The psychedelics industry has grown significantly these past few years. However, before it can deliver on its potential, the sector will need to achieve various milestones and overcome certain challenges. Below, we look at some of the trends that may shape this burgeoning industry in 2023. Drug approvals Companies such as Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) and Compass Pathways have been conducting clinical trials on psychedelic drugs for the treatment of a range of conditions. These trials may make or break the psychedelic industry’s viability, which further highlights the huge role they can play in the…

Continue Reading

ThursdayDec 29, 2022 12:41 pm

California Senator Refiles Measure to Legalize Psychedelics in 2023

Senator Scott Wiener of California has filed a measure to legalize the possession of a number of psychedelics. This comes after his office announced earlier this week that Wiener would be introducing the revised bill again in 2023. The revised bill will revoke state law that prohibits any mycelium or spores capable of producing mushrooms that contain psilocin or psilocybin. Psilocybin and psilocin are two of the major psychoactive components found in magic mushrooms. The ban on drug paraphernalia imposed on the substances mentioned in the state of California will also be repealed under the revised bill. During a phone…

Continue Reading

WednesdayDec 28, 2022 11:49 am

Psychedelic Therapy May Soon Feature in Health Benefits

Every few years, new or previously forgotten discoveries shake up the very foundation of how industries operate. The development of the internet, for instance, altered society in a multitude of ways, enabling previously unknown ways of connecting and thinking and completely revolutionizing how society functions. Psychedelics are poised to transform the psychiatric industry in a similar way. Mental illness has gripped the American populace for decades now, with reports showing that mental health in America has been getting worse for quite a while now. Although pharmaceutical medications can be used to treat mental disorders, they often come with a multitude…

Continue Reading

TuesdayDec 27, 2022 2:12 pm

Quebec Becomes First Province in Canada to Cover Psilocybin Therapy Costs

The province of Quebec recently became the first in Canada to cover expenses associated with psilocybin therapy. This comes as the use of psychedelics in mental health care gains popularity across Canada as well as neighboring countries such as the United States. Therapsil, a nonprofit healthcare advocacy focused on expanding legal, equitable and safe access to psilocybin-assisted therapy, was involved. The advocacy group confirmed that after getting permission from Health Canada, two doctors had succeeded in billing the province of Quebec for treatment using psilocybin-assisted psychotherapy, noting that the entire process had been legal. This marks a turning point in…

Continue Reading

ThursdayDec 22, 2022 12:36 pm

Study Suggests That Psilocybin Boosts Mindfulness

Over the past couple of years, Big Pharma and investors have poured millions of dollars into psychedelic research. Initial studies have found that psychedelic drugs such as psilocybin, mescaline and ketamine may offer significant mental health benefits. When paired with physiotherapy, these hallucinogenic drugs can deliver profound benefits against conditions such as post-traumatic stress disorder, depression, and eating disorders. Studies have indicated that psychedelics deliver these benefits by causing users to have profound changes in patients' beliefs about consciousness, meaning and purpose. A recently published study sought to understand the association between serotonin receptors, mystical-like experiences, mindfulness and psilocybin. Psilocybin…

Continue Reading

WednesdayDec 21, 2022 11:33 am

Christmas As We Know It May Be Based On Psychedelic Traditions

We’ve all heard about Santa’s reindeer flying around the world as Santa drops off presents for kids who have been nice all year. Have you ever thought about how these animals fly though? If you guessed psychedelics, you may be right. Some historians argue that Father Christmas is a psychedelic mushroom shaman, as shown by his red-and-white suit, which bears resemblance to the psychedelic fly agaric mushroom. This mushroom, scientifically known as Amanita muscaria, is bright red with white flecks. Historical evidence on indigenous psychedelic shamanism in northern Europe and Siberia even suggests that the Christmas we know today is…

Continue Reading

PsychedelicNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000